Literature DB >> 21553024

MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells.

Yanjie Guo1, Sheng Li, Jianhua Qu, Shujing Wang, Yibing Dang, Jianhui Fan, Shengjin Yu, Jianing Zhang.   

Abstract

MicroRNAs are small non-coding RNAs that regulate the expression of other genes in a post-transcriptional manner. MiR-34a can induce apoptosis, cell cycle arrest, and senescence. However, its role in tumor progress remains to be fully elucidated. In the present study, the role of miR-34a in lymphatic metastasis was investigated using mouse hepatocarcinoma cell lines Hca-F and Hepa1-6. MicroRNA profiling and Hairpin-RT-PCR analysis showed that the expression level of miR-34a was higher in Hepa1-6 cells (of no metastatic ability) than that in Hca-F cells (of high metastatic ability). Ectopic expression of miR-34a can inhibit cell growth and cell invasion in Hepa1-6 and Hca-F cells. Moreover, miR-34a triggers G1 arrest and down-regulates CyclinD1 and CDK6 in Hepa1-6 cells. Furthermore, we proved that miR-34a decreased adhesion of Hca-F cells to regional lymph node in vitro, reduced lymph nodes-metastasized burden, and inhibited tumor lymph node metastases in vivo. All these results suggest that miR-34a plays multiple tumor suppressive roles in murine hepatocarcinoma, not only inhibiting cell growth by cell cycle arrest, but also repressing metastasis, and may serve as a novel therapeutic target for hepatocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553024     DOI: 10.1007/s11010-011-0827-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

3.  Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer.

Authors:  B D Minsky; C Mies; T A Rich; A Recht
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-08       Impact factor: 7.038

4.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 5.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

6.  Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

Authors:  Valery Tarasov; Peter Jung; Berlinda Verdoodt; Dmitri Lodygin; Alexey Epanchintsev; Antje Menssen; Gunter Meister; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-05-11       Impact factor: 4.534

7.  CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.

Authors:  Li Jia; Jun Cao; Wei Wei; Shujing Wang; Yunfei Zuo; Jianing Zhang
Journal:  Int J Biochem Cell Biol       Date:  2007-06-28       Impact factor: 5.085

Review 8.  microRNAs and cancer: an overview.

Authors:  Pedro P Medina; Frank J Slack
Journal:  Cell Cycle       Date:  2008-08-17       Impact factor: 4.534

9.  Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor.

Authors:  Siu Tim Cheung; Xin Chen; Xin Yuan Guan; San Yu Wong; Lai Shan Tai; Irene O L Ng; Samuel So; Sheung Tat Fan
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

View more
  17 in total

Review 1.  Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Yiwei Li; Aamir Ahmad; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2014-01       Impact factor: 3.828

2.  CRKII overexpression promotes the in vitro proliferation, migration and invasion potential of murine hepatocarcinoma Hca-P cells.

Authors:  Zanmei Zhou; Xiuyan Sun; Chunmei Guo; Ming-Zhong Sun; Shuqing Liu
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

Review 3.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 4.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

5.  The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.

Authors:  Ji Hyung Hong; Kang San Roh; Sung-Suk Suh; Sukchan Lee; Sook Whan Sung; Jae Kil Park; Jae Ho Byun; Jin Hyoung Kang
Journal:  Tumour Biol       Date:  2015-06-25

6.  Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.

Authors:  Molykutty John-Aryankalayil; Sanjeewani T Palayoor; Adeola Y Makinde; David Cerna; Charles B Simone; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Radiat Res       Date:  2012-07-24       Impact factor: 2.841

Review 7.  Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.

Authors:  Bin Bao; Aamir Ahmad; Asfar S Azmi; Shadan Ali; Fazlul H Sarkar
Journal:  Curr Protoc Pharmacol       Date:  2013-06

Review 8.  MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.

Authors:  Iván Lyra-González; Laura E Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  World J Hepatol       Date:  2015-06-18

9.  Altering β-cell number through stable alteration of miR-21 and miR-34a expression.

Authors:  Marie Balslev Backe; Guy Wayne Novotny; Dan Ploug Christensen; Lars Groth Grunnet; Thomas Mandrup-Poulsen
Journal:  Islets       Date:  2014       Impact factor: 2.694

10.  miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.

Authors:  Yi Han; Yubo Liu; Xirao Fu; Qi Zhang; Huang Huang; Cheng Zhang; Wenli Li; Jianing Zhang
Journal:  J Physiol Biochem       Date:  2018-07-13       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.